Daratumumab Based Response Adapted Therapy for Older Adults With Newly Diagnosed Multiple Myeloma

Condition:   Multiple Myeloma Interventions:   Drug: Daratumumab Injection;   Drug: Dexamethasone Oral;   Drug: Lenalidomide Pill;   Drug: Bortezomib Injection Sponsors:   H. Lee Moffitt Cancer Center and Research Institute;   Janssen Scientific Affairs, LLC Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials